Search results

Selected filters:

Europe

Article type

Topic

Sector

Jurisdictions

22,841 results found for your search

Sort options
19 November 2019

Shorter EPO opposition process requires new approaches from life sciences patentees

Strategies employed not only by rights owners but also by those opposing their grants will need to be recalibrated to reflect the new realities

16 November 2019

Patents are politics, as an eagerly awaited UK Supreme Court FRAND licensing ruling may soon show

A judgment that upholds the Unwired Planet and Conversant decisions could well leave British Prime Minister Boris Johnson in a difficult position

15 November 2019

Google’s acquisition of Fitbit proves that data is king  

Should it be approved, the tie-up will strengthen the tech giant’s position in a high-growth industry and will also give it the tools to penetrate the healthcare market

15 November 2019

Another big LG assertion could signal a strategy shift

The Korean electronics giant has accused TCL of infringement in Germany, in another lawsuit targeting a Chinese rival

14 November 2019

Skyhawk deal with Celgene confirms growing importance of platform technologies in life sciences IP value creation

Increased focus on gene and cell-related therapies as well as falling R&D returns, promise to heighten biopharma interest in tapping into the potential of SkySTAR and other platforms

13 November 2019

EPO agreement to boost Chinese companies' Europe push

Foreign companies with R&D in China may also benefit from deal opening up PCT search options

12 November 2019

US government patent suit against Gilead could be a sign of things to come

After months of Truvada controversy, Department of Justice files multi-billion dollar case against Gilead, claiming the company has declined to take a licence to its HIV PrEP rights since in 2016

11 November 2019

It is time for the German courts to be courageous on FRAND

The Dusseldorf Court of Appeal’s decision in Unwired Planet v Huawei is one that had licensees cheering and licensors in despair - but it may not last long 

09 November 2019

The patent dodgers trolling the IP landscape

IPCom is one of Europe’s oldest NPEs – and usually one of its most reticent. Not anymore, though. In this opinion piece, managing director Pio Suh explains why he believes firms such as his have a key role to play in FRAND licensing

08 November 2019

Catch up on the most important life sciences IP developments from the past month

Read our most recent monthly round-up for key pharma and biotech IP stories from October 2019

08 November 2019

A snapshot of the global patent landscape in eight charts  

A recently issued WIPO report based on multiple data points sheds light on the state of play in worldwide patenting activity

06 November 2019

Supreme Court rules that Italian patent can survive when parallel European patent is rejected

Clarifying previous case law, the Supreme Court has stated that when two semi-identical European and Italian patents exist for the same invention and the European patent is rejected by a final decision, Italian courts are free to ignore the European decisions and conclude that the Italian patent remains valid under Italian law.

06 November 2019

Poland goes the extra mile with new guarantee marks

On 16 March 2019 the Polish Industrial Property Law underwent significant changes with regard to trademarks, in an effort to align it with the EU Trademarks Directive (2015/2436). One of the most significant alterations is the introduction of so-called ‘guarantee marks’, which replace the previous, scarcely regulated ‘collective guarantee marks’.

06 November 2019

New report reveals why SMEs want patents and the opportunities they bring

Study released by the European Patent Office sheds light on the growing sophistication of smaller businesses seeking protection for their inventions

06 November 2019

Reverting a non-examined patent to an examined patent during court proceedings

A recent case involving two automotive companies has highlighted that third parties that file patent invalidation actions against a non-examined patent should be prepared for a possible request for conversion by the patent owner.